For example, STAT1 and CXCL9 were highly expressed in the RUQ and liver metastases; CXCL9 is well known as a potent T cell chemokine (Liao et al., 1995, Rainczuk et al., 2012), and high expression of CXCL9 and CXCL10 correlate with enhanced T cell infiltration of tumors and better survival of ovarian cancer patients (Bronger et al., 2016). Here, CXCL10 is linked to ovarian cancer.